Research Article

The protective effects of Selenium and Boron against Cyclophosphamide-induced bone marrow and blood toxicity: An in vivo study

Volume: 15 Number: 2 August 15, 2022
EN TR

The protective effects of Selenium and Boron against Cyclophosphamide-induced bone marrow and blood toxicity: An in vivo study

Abstract

Thanks to their antioxidant, anti-apoptotic, anti-lipid peroxidative, and immune-boosting properties, Boron (B) and Selenium (Se) are essential trace elements for the human body. This study aims to compare the myeloid protective potentials of Se and B in Cyclophosphamide (CP)-induced bone-marrow and haematological toxicity in experimental rats considering that the myelotoxic property of this anti-cancer drug limits its use. We hypothesized that selenium has a better protective effect than boron in preventing the toxic effects of CP on bone marrow and blood cells. 1.5 mg/kg of Se and 20 mg/kg of B, which are the most frequently used optimal doses of these trace elements, were given to the animals intraperitoneally throughout the experiment. 200 mg/kg of CP was administered only on the 4th day. The animals were sacrificed to take the blood and bone marrow samples to be stored for hematological evaluations. The CP administration significantly decreased leukocyte (WBC), thrombocyte (PLT), erythrocytes (RBC), and bone marrow nucleated cell counts. On the other hand, they increased in significant amounts in the groups given Se and B along with CP when compared to those given only CP. However, Se proved to be more protective than B in preventing CP-induced bone marrow and hematologic toxicity despite not achieving statistical significance. It was, therefore, concluded that the doses used in this experiment were successful in protecting against CP-induced damage to the bone marrow and CP-related hematological toxicity.

Keywords

References

  1. [1] Thun, M. J., DeLancey, J. O., Center, M. M., Jemal, A., and Ward, E. M. (2010). The global burden of cancer: priorities for prevention, Carcinogenesis 31 100-110.
  2. [2] Iqubal, A., Iqubal, M. K., Sharma, S., Ansari, M. A., Najmi, A. K., Ali, S. M., Ali, J., and Haque, S. E. (2019). Molecular mechanism involved in cyclophosphamide-induced cardiotoxicity: Old drug with a new vision, Life Sciences 218, 112-131.
  3. [3] Ashry, N. A., Gameil, N. M., and Suddek, G. M. (2013). Modulation of cyclophosphamide-induced early lung injury by allicin, Pharmaceutical Biology, 51 806-811.
  4. [4] Kalaycioglu, M. E., Lichtin, A. E., Andresen, S. W., Tuason, L., and Bolwell, B. (1995). High-dose busulfan and cyclophosphamide followed by autologous bone marrow transplantation and/or peripheral blood progenitor cell rescue for metastatic breast cancer. American Journal of Clinical Oncology 18, 491-494.
  5. [5] Kumar, K., and Kuttan, R. J. P. (2005). Chemoprotective activity of an extract of Phyllanthus amarus against cyclophosphamide induced toxicity in mice. Phytomedicine 12, 494-500.
  6. [6] Senthilkumar, S., Devaki, T., Manohar, B. M., and Babu, M. S. (2006). Effect of squalene on cyclophosphamide-induced toxicity. Clinica Chimica Acta 364, 335-342.
  7. [7] Ozabacigil, F., Beydemir, S., Ciftci, M., Gumustekin, K., and Bakan, N. (2008). Cisplatin and 5-fluorouracil inhibits 6-phosphogluconate dehydrogenase activity in human erythrocytes in vitro and in vivo. Asian Journal of Chemistry 20, 3189.
  8. [8] Cengiz, M. (2018). Hematoprotective effect of boron on cyclophosphamide toxicity in rats. Cellular and Molecular Biology 64, 62-65.

Details

Primary Language

English

Subjects

Biochemistry and Cell Biology (Other)

Journal Section

Research Article

Publication Date

August 15, 2022

Submission Date

June 2, 2022

Acceptance Date

July 12, 2022

Published in Issue

Year 2022 Volume: 15 Number: 2

APA
Ayhancı, A., Lafçı, N., Musmul, A., Gür, F., Vejselova Sezer, C., Kulcanay Şahin, İ., Gür, B., Bilici, N., Onur, S., & Cengiz, M. (2022). The protective effects of Selenium and Boron against Cyclophosphamide-induced bone marrow and blood toxicity: An in vivo study. Biological Diversity and Conservation, 15(2), 256-264. https://doi.org/10.46309/biodicon.2022.1124346
AMA
1.Ayhancı A, Lafçı N, Musmul A, et al. The protective effects of Selenium and Boron against Cyclophosphamide-induced bone marrow and blood toxicity: An in vivo study. BioDiCon. 2022;15(2):256-264. doi:10.46309/biodicon.2022.1124346
Chicago
Ayhancı, Adnan, Nilüfer Lafçı, Ahmet Musmul, et al. 2022. “The Protective Effects of Selenium and Boron Against Cyclophosphamide-Induced Bone Marrow and Blood Toxicity: An in Vivo Study”. Biological Diversity and Conservation 15 (2): 256-64. https://doi.org/10.46309/biodicon.2022.1124346.
EndNote
Ayhancı A, Lafçı N, Musmul A, Gür F, Vejselova Sezer C, Kulcanay Şahin İ, Gür B, Bilici N, Onur S, Cengiz M (August 1, 2022) The protective effects of Selenium and Boron against Cyclophosphamide-induced bone marrow and blood toxicity: An in vivo study. Biological Diversity and Conservation 15 2 256–264.
IEEE
[1]A. Ayhancı et al., “The protective effects of Selenium and Boron against Cyclophosphamide-induced bone marrow and blood toxicity: An in vivo study”, BioDiCon, vol. 15, no. 2, pp. 256–264, Aug. 2022, doi: 10.46309/biodicon.2022.1124346.
ISNAD
Ayhancı, Adnan - Lafçı, Nilüfer - Musmul, Ahmet - Gür, Fatma - Vejselova Sezer, Canan - Kulcanay Şahin, İlknur - Gür, Bahri - Bilici, Namık - Onur, Suzan - Cengiz, Mustafa. “The Protective Effects of Selenium and Boron Against Cyclophosphamide-Induced Bone Marrow and Blood Toxicity: An in Vivo Study”. Biological Diversity and Conservation 15/2 (August 1, 2022): 256-264. https://doi.org/10.46309/biodicon.2022.1124346.
JAMA
1.Ayhancı A, Lafçı N, Musmul A, Gür F, Vejselova Sezer C, Kulcanay Şahin İ, Gür B, Bilici N, Onur S, Cengiz M. The protective effects of Selenium and Boron against Cyclophosphamide-induced bone marrow and blood toxicity: An in vivo study. BioDiCon. 2022;15:256–264.
MLA
Ayhancı, Adnan, et al. “The Protective Effects of Selenium and Boron Against Cyclophosphamide-Induced Bone Marrow and Blood Toxicity: An in Vivo Study”. Biological Diversity and Conservation, vol. 15, no. 2, Aug. 2022, pp. 256-64, doi:10.46309/biodicon.2022.1124346.
Vancouver
1.Adnan Ayhancı, Nilüfer Lafçı, Ahmet Musmul, Fatma Gür, Canan Vejselova Sezer, İlknur Kulcanay Şahin, Bahri Gür, Namık Bilici, Suzan Onur, Mustafa Cengiz. The protective effects of Selenium and Boron against Cyclophosphamide-induced bone marrow and blood toxicity: An in vivo study. BioDiCon. 2022 Aug. 1;15(2):256-64. doi:10.46309/biodicon.2022.1124346

Cited By

❖  Biological Diversity and Conservation (BioDiCon) is an international, peer-reviewed, open-access journal that publishes high-quality scientific research in biodiversity, conservation biology, ecology, life sciences, environmental sciences, and related health sciences.

❖  The journal is committed to maintaining the highest standards of publication ethics and follows the principles and guidelines of the Committee on Publication Ethics (COPE).

❖  All articles are published under the Creative Commons Attribution 4.0 International (CC BY 4.0) License.

❖  Only manuscripts written in clear and grammatically correct English are accepted.

❖   There is no article processing charge (APC).

❖  Indexes: Additional Web of Science Indexes: Zoological Record, TR Dizin, Medical Reads (RRS), CrossRef;10.46309/biodicon.



❖  Editorial Office

Biological Diversity and Conservation (BioDiCon)

Sazova Mahallesi, Ziraat Caddesi, No.277, F Blok, 26005 Tepebaşı-Eskişehir, Türkiye

Email: info@biodicon.com; biodicon@gmail.com

 Editor-in-Chief: Prof.Dr. Ersin YÜCEL (https://orcid.org/0000-0001-8274-7578)

Website: https://dergipark.org.tr/en/pub/biodicon; http://www.biodicon.com

Publication Start Date 2008 
Publisher: ERSİN YÜCEL (Publisher ID: F2600000047; DergiPark ID: 2067)